CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Exit or restructuring costs · Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 5,823 shares at $0.84 ($4,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 5,606 shares at $0.87 ($4,901)
- 4 Open-market buy Chief Executive Officer bought 5,040 shares at $0.97 ($4,900)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 7,027 shares at $0.70 ($4,901)
- 8-K Event Delisting notice
- 4 Open-market buy Chief Executive Officer bought 6,839 shares at $0.72 ($4,901)
- 4 Open-market buy Chief Executive Officer bought 6,783 shares at $0.74 ($4,995)
Page 9 of 16 · 309 filings